Inventor · disambiguated record
Paul L. Kornblith
Also filed as: KORNBLITH PAUL · KORNBLITH PAUL L
17 granted patents·6 pending applications·667 citations·filing 1996–2011
96Inventor score
Top patents by PatentIndex Score
23 records- 0198US7678552B2Method for selecting therapeutic agents for cancer treatmentPRECISION THERAPEUTICS INC·Filed 2008·Granted Mar 16, 2010·96 cites·59 claims
- 0297US5728541AMethod for preparing cell cultures from biologial specimens for chemotherapeutic and other assaysPRECISION THERAPEUTICS INC·Filed 1996·Granted Mar 17, 1998·127 cites·7 claims
- 0396US7314731B2Method for selecting therapeutic agents for cancerPRECISION THERAPEUTICS INC·Filed 2005·Granted Jan 1, 2008·25 cites·29 claims
- 0496US7112415B2Method of preparing cell cultures from biological specimens for assaying a response to an agentPRECISION THERAPEUTICS INC·Filed 2005·Granted Sep 26, 2006·34 cites·35 claims
- 0596US6933129B1Method for culturing and assaying cellsPRECISION THERAPEUTICS INC·Filed 1998·Granted Aug 23, 2005·108 cites·7 claims
- 0696US6887680B2Method for preparing cell cultures from biological specimens for chemotherapeutic and other assaysPRECISION THERAPEUTICS INC·Filed 2002·Granted May 3, 2005·52 cites·14 claims
- 0794US7501260B2Methods for determining efficacy of chemotherapeutic agents for a patient prior to treatmentPRECISION THERAPEUTICS INC·Filed 2007·Granted Mar 10, 2009·16 cites·38 claims
- 0893US7575868B2Methods for assessing efficacy of chemotherapeutic agentsPRECISION THERAPEUTICS INC·Filed 2007·Granted Aug 18, 2009·15 cites·17 claims
- 0993US7563593B2Method for preparing cell cultures from biological specimens for assaying secreted factorsPRECISION THERAPEUTICS INC·Filed 2006·Granted Jul 21, 2009·13 cites·12 claims
- 1092US6416967B2Method of using multicellular particulates to analyze malignant or hyperproliferative tissuePRECISION THERAPEUTICS INC·Filed 1998·Granted Jul 9, 2002·113 cites·22 claims
- 1190US7829288B2Methods for assessing efficacy of chemotherapeutic agentsPRECISION THERAPEUTICS INC·Filed 2009·Granted Nov 9, 2010·7 cites·29 claims
- 1290US6900027B1Method for preparing cell cultures from biological specimens for chemotherapeutic and other assaysPRECISION THERAPEUTICS INC·Filed 1998·Granted May 31, 2005·51 cites·8 claims
- 1386US7771963B2Methods for determining efficacy of chemotherapeutic agentsPRECISION THERAPEUTICS INC·Filed 2008·Granted Aug 10, 2010·4 cites·25 claims
- 1483US8039213B2Methods for assessing efficacy of chemotherapeutic agentsPRECISION THERAPEUTICS INC·Filed 2010·Granted Oct 18, 2011·2 cites·16 claims
- 1578US8058025B2Methods for determining efficacy of chemotherapeutic agentsKORNBLITH PAUL L·Filed 2010·Granted Nov 15, 2011·2 cites·18 claims
- 1674US8183009B2Assaying cellular markers for the evaluation of tumorsKORNBLITH PAUL L·Filed 2010·Granted May 22, 2012·1 cites·7 claims
- 1761US2004072722A1Methods for assessing efficacy of chemotherapeutic agentsFiled 2003·Application pending·0 cites
- 1860US2012088264A1Methods for determining efficacy of chemotherapeutic agentsKORNBLITH PAUL L·Filed 2011·Application pending·0 cites
- 1958US7972769B2Method for preparing cell cultures from biological specimens for chemotherapeutic and other assaysPRECISION THERAPEUTICS INC·Filed 2006·Granted Jul 5, 2011·1 cites·21 claims
- 2051US2007258886A1Methods for assessing cell labelingCELSENSE INC·Filed 2007·Application pending·0 cites
- 2149US2004086888A1Method for tandem genomic/proteomic analysis of proliferating cellsFiled 2001·Application pending·0 cites
- 2239US2004023375A1Method for preparing cell cultures from biological specimens for chemotherapeutic and other assaysPRECISION THERAPEUTICS INC·Filed 2002·Application pending·0 cites
- 2330US2002168679A1Staining agents and protocols for characterizing malignant cells in cultureFiled 1998·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Paul L. Kornblith files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →